Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARIH2 opposite strand long non-coding RNA (ARIH2OS) is a transcript identified as a long non-coding RNA (lncRNA) from the region opposite the ARIH2 gene on human chromosome 3, and is also known by synonyms including C3orf71 and Ariadne-2 homolog opposite strand protein. Long non-coding RNAs are RNA molecules longer than 200 nucleotides which are not translated into protein and are generally involved in the regulation of gene expression, chromatin modification, transcriptional control, or post-transcriptional modulation[1][5]. While lncRNAs have been increasingly recognized for their regulatory capacity, specific biological functions of ARIH2OS itself remain uncharacterized, and no evidence supports its role as a conventional therapeutic target such as a receptor, enzyme, transporter, or direct drug target. There are also no documented drugs, biomarkers, or disease mechanistic associations uniquely attributed to ARIH2OS in current scientific literature. However, its classification as a lncRNA means it may participate in regulatory pathways or disease mechanisms still to be elucidated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARIH2 opposite strand long non-coding RNA (ARIH2OS).